Gilead Sciences (NASDAQ:GILD) reported quarterly earnings of $1.90 per share which beat the analyst consensus estimate of $1.70 by 11.76 percent. This is a 10.47 percent increase over earnings of $1.72 per share from the same period last year. The company reported quarterly sales of $7.569 billion which beat the analyst consensus estimate of $7.137 billion by 6.06 percent. This is a 6.38 percent increase over sales of $7.115 billion the same period last year.